Evidence map›Paper›PMID 28053228›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Diverse evolutionary patterns of pneumococcal antigens identified by pangenome-wide immunological screening.

Nicholas J Croucher, Joseph J Campo, Timothy Q Le, Xiaowu Liang, Stephen D Bentley, William P Hanage, Marc Lipsitch

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Defining thebioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Naturally acquired adaptive immunity toClinical & translational immunology · 2024
    Article
  15. Immunization with recombinantExperimental biology and medicine (Maywood, N.J.) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Nicholas J CroucherDepartment of Infectious Disease Epidemiology, Imperial College London, London W2 1PG, United Kingdom; n.croucher@imperial.ac.uk.
Joseph J CampoAntigen Discovery Inc., Irvine, CA 92618.
Timothy Q LeAntigen Discovery Inc., Irvine, CA 92618.
Xiaowu LiangAntigen Discovery Inc., Irvine, CA 92618.
Stephen D BentleyInfection Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom.
William P HanageCenter for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health, Boston, MA 02115.
Marc LipsitchCenter for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health, Boston, MA 02115.
Antigen Discovery (United States) · USCenter for Disease Dynamics, Economics & Policy · USImperial College London · GBWellcome Sanger Institute · GB

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI LIPSITCH, MARC · 2009 to 2018
$26.4M
VACCINATION AND THE EVOLUTIONARY DYNAMICS OF PNEUMOCOCCIR01AI048935 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LIPSITCH, MARC · 2001 to 2016
$8.8M
Post-PCV pneumococcal population genetics and resistanceR01AI066304 · NIAID · HARVARD PILGRIM HEALTH CARE, INC. · PI FINKELSTEIN, JONATHAN A · 2006 to 2014
$6.4M
NIAID NIH HHS R01 AI048935NIAID NIH HHS R01 AI066304NIGMS NIH HHS U54 GM088558Wellcome Trust 098051Wellcome Trust 104169/Z/14/Z
6 · The paper itself

Abstract

Characterizing the immune response to pneumococcal proteins is critical in understanding this bacterium's epidemiology and vaccinology. Probing a custom-designed proteome microarray with sera from 35 healthy US adults revealed a continuous distribution of IgG affinities for 2,190 potential antigens from the species-wide pangenome. Reproducibly elevated IgG binding was elicited by 208 "antibody binding targets" (ABTs), which included 109 variants of the diverse pneumococcal surface proteins A and C (PspA and PspC) and zinc metalloprotease A and B (ZmpA and ZmpB) proteins. Functional analysis found ABTs were enriched in motifs for secretion and cell surface association, with extensive representation of cell wall synthesis machinery, adhesins, transporter solute-binding proteins, and degradative enzymes. ABTs were associated with stronger evidence for evolving under positive selection, although this varied between functional categories, as did rates of diversification through recombination. Particularly rapid variation was observed at some immunogenic accessory loci, including a phage protein and a phase-variable glycosyltransferase ubiquitous among the diverse set of genomic islands encoding the serine-rich PsrP glycoprotein. Nevertheless, many antigens were conserved in the core genome, and strains' antigenic profiles were generally stable. No strong evidence was found for any epistasis between antigens driving population dynamics, or redundancy between functionally similar accessory ABTs, or age stratification of antigen profiles. These results highlight the paradox of why substantial variation is observed in only a subset of epitopes. This result may indicate only some interactions between immunoglobulins and ABTs clear pneumococcal colonization or that acquired immunity to pneumococci is an accumulation of individually weak responses to ABTs evolving under different levels of functional constraint.

Indexed as

Adhesins, BacterialAdultAntibodies, BacterialAntibody FormationAntigens, BacterialBacterial ProteinsEpitopesHumansImmunoglobulin GMembrane ProteinsMembrane Transport ProteinsPneumococcal InfectionsPneumococcal VaccinesStreptococcus pneumoniaeAdhesins, BacterialAntibodies, BacterialAntigens, BacterialBacterial ProteinsEpitopesImmunoglobulin GMembrane ProteinsMembrane Transport ProteinsPneumococcal Vaccinesepidemiologyevolutiongenomicsimmunologypathogens

Identifiers

PMID28053228
PMCPMC5255586
OpenAlexW2569480712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.